Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Lapatinib will prevent radiation-induced increase in Transforming Growth Factor alpha (TGFα),
an important growth factor in cancer cell recovery after ionizing irradiation.